The Progress of Thyroid Cancer in The Covid 19 Period
Abstract
Methods : Our study includes a comparative analysis of two patient groups treated for thyroid cancer. Patients who were treated for thyroid cancer between 11 April 2018 and 11 March 2020 were included in Group 1, and patients who were treated for thyroid cancer between 11 March 2020 and 11 February 2022 during the COVID-19 epidemic were included in Group 2.
Results: Groups 1 and 2 included 163 and 117 patients, respectively. Patients with preoperative fine-needle aspiration biopsy (FNAB) as potentially malignant or malignant were significantly higher in Group 2 (p=0.001). When compared according to the postoperative pathological diagnoses, there was a significant difference between the groups, poorly differentiated thyroid cancer was more common in Group 2 (p=0.018). Pathological tumour diameter was significantly larger in Group 2 (p=0.001).
Conclusions: Patients with suspicious findings in terms of thyroid diseases and cancer applied to the hospital later, both because of the fear of contracting COVID-19 and as a result of the pandemic measures recommended and implemented by all world health authorities. These patients applied to the hospital with their complaints gradually increasing in the following periods, parallel to this, there was a delay in the diagnosis of thyroid cancer and the disease could be detected at a more advanced stage.
Keywords
References
- 1. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006;18:2164-2167. https://doi.org/10.1001/jama.295.18.2164.
- 2. Adas G, Adas M, Özülker F, Akçakaya A. Thyroid Cancers. Okmeydanı Med J, 2012, 28: 26-34. https://doi.org/10.5222/otd.supp1.2012.026.
- 3. Jameson JL, De Groot JL. Endocrinology adult and pediatric. In: Pacini F, Marchisotta S, De Groot JL. Thyroid neoplasia. Saunders Elsevier, 6th edition, Philadelphia 2010:1668-1701.
- 4. World Health Organization. Pneumonia of Unknown Cause- China. WHO; 2020. Available from: https://www.who.int/csr/don/05-january-2020-pneumonia-of-unkown-cause-china/en/. Accessed in 2020 (April 3).
- 5. Chan Jasper FW, Yuan SF, Kok KH, To Kelvin KW, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2019; 395: 514– 23. https://doi.org/ 10.1016/S0140-6736(20)30154-9.
- 6. World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19. WHO; 2020. Available from: https:// www.who.int/director-general/speeches/detail/who-directorgeneral-s-opening-remarks-at-the-media-briefing-on-covid-19---11- march-2020. Accessed in 2020 (March 11).
- 7. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020;395:565-574. https://doi.org/ 10.1016/S0140-6736(20)30251-8.
- 8. Wong LE, Hawkins JE, Langness S, Murrell KL, Iris P, Sammann A. Where Are All the Patients? Addressing Covid-19 Fear to Encourage Sick Patients to Seek Emergency Care. NEJM Catalyst Innovations In Care Delivery. 2020. Available from: https://catalyst.nejm.org/doi/full/10.1056/CAT.20.0193. Accessed in 2021 (Jul 1).
Details
Primary Language
English
Subjects
Health Care Administration
Journal Section
Research Article
Authors
Mikail Uyan
*
0000-0003-4595-4345
Türkiye
Kadir Tomas
0000-0003-4129-5725
Türkiye
Süleyman Kalcan
0000-0002-0829-7334
Türkiye
Ali Özdemir
0000-0002-6435-1868
Türkiye
Gökhan Demiral
0000-0003-2807-5437
Türkiye
Ahmet Pergel
0000-0002-0163-887X
Türkiye
Publication Date
June 30, 2022
Submission Date
May 19, 2022
Acceptance Date
June 18, 2022
Published in Issue
Year 2022 Volume: 44 Number: 2